[
  {
    "ts": null,
    "headline": "Ionis (IONS) Announces Leadership Transition as R&D Veteran Richard Geary Prepares to Retire",
    "summary": "Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is one of the 10 biotech stocks screaming a buy. On June 12, the company announced the upcoming retirement of Richard Geary, Ph.D., its executive vice president and chief development officer, effective January 2026. Holly Kordasiewicz, Ph.D., currently senior vice president of neurology, will take over the role. Geary has been […]",
    "url": "https://finnhub.io/api/news?id=aca5d67fcbd0f3286119150b0f26ab33f9526dae16eaeee9b4c29282c07e7864",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750450035,
      "headline": "Ionis (IONS) Announces Leadership Transition as R&D Veteran Richard Geary Prepares to Retire",
      "id": 135446168,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is one of the 10 biotech stocks screaming a buy. On June 12, the company announced the upcoming retirement of Richard Geary, Ph.D., its executive vice president and chief development officer, effective January 2026. Holly Kordasiewicz, Ph.D., currently senior vice president of neurology, will take over the role. Geary has been […]",
      "url": "https://finnhub.io/api/news?id=aca5d67fcbd0f3286119150b0f26ab33f9526dae16eaeee9b4c29282c07e7864"
    }
  }
]